103
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera

, , , &
Pages 586-588 | Received 08 Oct 2007, Accepted 11 Dec 2007, Published online: 01 Jul 2009

References

  • Levine R L, Pardanani A, Tefferi A, Gilliland D G. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7: 673–683
  • Scott L M, Tong W, Levine R L, Scott M A, Beer P A, Stratton M R, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007; 356: 459–468
  • Pardanani A, Lasho T L, Finke C, Hanson C A, Tefferi A. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007; 21: 1960–1963
  • Scott L M, Beer P A, Bench A J, Erber W N, Green A R. Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera. Br J Haematol 2007; 139: 511–512
  • Butcher C M, Hahn U, To L B, Gecz J, Wilkins E J, Scott H S, et al. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia 2007, Oct 4 [Epub ahead of print]
  • Colaizzo D, Amitrano L, Tiscia G L, Grandone E, Guardascione M A, Margaglione M. A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood 2007; 110: 2768
  • Williams D M, Kim A H, Rogers O, Spivak J L, Moliterno A R. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Exp Hematol 2007; 35: 1641–1646
  • Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2007, Nov 6 [Epub ahead of print]
  • Tefferi A, Thiele J, Orazi A, Kvasnicka H M, Barbui T, Hanson C A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092–1097
  • Jones A V, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162–2168

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.